Humasis Co. Ltd. (KOSDAQ:205470)
South Korea · Delayed Price · Currency is KRW 4,265.00
+120.00 (2.90%)
May 21, 2026, 3:30 PM KST
Humasis Market Cap
Humasis has a market cap or net worth of 93.8 billion as of May 21, 2026. Its market cap has decreased by -43.49% in one year.
Market Cap
93.80B
Enterprise Value
-79.08B
Revenue
30.11B
Ranking
n/a
PE Ratio
n/a
Stock Price
4,265.00
Market Cap Chart
Since September 27, 2017, Humasis's market cap has increased from 10.76B to 93.80B, an increase of 771.53%. That is a compound annual growth rate of 28.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 93.80B | -18.24% |
| Dec 30, 2025 | 114.74B | -38.06% |
| Dec 30, 2024 | 185.23B | -22.80% |
| Dec 28, 2023 | 239.92B | -47.44% |
| Dec 29, 2022 | 456.45B | -20.07% |
| Dec 30, 2021 | 571.04B | 75.79% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 27, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 62.31T |
| Celltrion | 38.25T |
| ALTEOGEN | 19.61T |
| Samsung Epis Holdings | 11.56T |
| P&S Robotics | 98.89B |
| CKD Bio | 97.81B |
| iNtRON Biotechnology | 97.05B |
| DK Life Science | 95.31B |